{"organizations": [], "uuid": "a37dbc57aa42ff6df170c3f619d932aebd465e4c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/02/06/globe-newswire-adherium-investor-conference-call.html", "country": "US", "domain_rank": 767, "title": "Adherium Investor Conference Call", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-07T01:20:00.000+02:00", "replies_count": 0, "uuid": "a37dbc57aa42ff6df170c3f619d932aebd465e4c"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/02/06/globe-newswire-adherium-investor-conference-call.html", "ord_in_thread": 0, "title": "Adherium Investor Conference Call", "locations": [], "entities": {"persons": [{"name": "adherium", "sentiment": "none"}, {"name": "rob turnbull", "sentiment": "none"}, {"name": "garth sutherland", "sentiment": "none"}, {"name": "arik anderson", "sentiment": "none"}], "locations": [{"name": "san mateo", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "new zealand", "sentiment": "none"}, {"name": "hong kong time", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}, {"name": "hong kong", "sentiment": "none"}, {"name": "united states", "sentiment": "none"}, {"name": "australia", "sentiment": "none"}], "organizations": [{"name": "vp finance and business services", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "SAN MATEO, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, will host a conference call on Wednesday, February 7, 2018 at 6:00pm EDT/Thursday, February 8, 2018 at 10:00am AEDT to discuss its Half Year Results to December 31, 2017.\nArik Anderson, Chief Executive Officer will host the call and will be joined by Adherium’s VP Finance and Business Services, Rob Turnbull, and Adherium’s Founder, Garth Sutherland.\nConference Call details:\nConference ID: 6589038\nDial-in Details:\nAustralia: 1800 123 296 or +61 2 8038 5221\nNew Zealand: 0800 452 782\nHong Kong: 800 908 865\nUnited States: 1 855 293 1544\nWebcast: http://www.openbriefing.com/OB/2812.aspx\nFor overseas participants, the conference call will commence at:\n- 12:00pm on Thursday, February 8, 2018 (New Zealand Daylight Time) - 7:00am on Thursday, February 8, 2018 (Hong Kong Time) - 3:00pm on Wednesday, February 7, 2018 (U.S. Pacific Daylight Time) - 6:00pm on Wednesday, February 7, 2018 (U.S. Eastern Daylight Time) A recording of the call will be made available in the ‘Investor Centre’ section of the Company website at http://adherium.com/investors/ and at http://www.openbriefing.com/\nAbout Adherium\nAdherium is a provider of digital health solutions. The Company develops, manufactures and supplies patients, pharmaceutical companies, healthcare providers and contract research organizations with the broadest range of \"smart\" medication sensors for respiratory medications to address sub-optimal medication use and improve health outcomes in chronic disease. Adherium is headquartered in the USA, and operates globally from bases in the USA, Europe and Australasia.\nInquiries\nUnited States :\nVik Panda, VikP@adherium.com\nLeigh Salvo, Gilmartin Group, leigh@gilmartinir.com , +1 415 937 5404\nEurope :\nScott Fleming, ScottF@adherium.com , +31 6 4687 6989\nAustralia:\nMichael Brown, Pegasus Corporate Advisory, +61 400 248 080\nEmail:\ninvestors@adherium.com\nWeb:\nwww.adherium.com\nSource:Adherium North America Inc", "external_links": ["https://www.globenewswire.com/Tracker?data=5uPg2cg1ys92-OVw7R9_1bONoBVPKSxpID8VcCSGW-Ub7Bd2yFnaQIbqg4pie-tas1bCbROWK4Fbs0X5OZasG883u51rQluvxEqUW4Pn2lzEBKdUzx9PW1CPkb6CcbeU", "https://www.globenewswire.com/Tracker?data=oFBZwBSaZvqUKF290TDSeUGS3uI6xe22e6zEyHY3kzdhTIZ25dBNMtf77D6Ej0wa-RYLahd3n0YjlSmU79MGa2Sz-ojB-6YPxj9IYXjfG6g=", "https://www.globenewswire.com/Tracker?data=NdCp5HLU8jhFz3JX3IQ-tabdbQxkS2fgou7OZ058ZW-EmyGNvCnpuwW2euXkOG2SQSMGFFzWaQmPub6zwxPzDw==", "https://www.globenewswire.com/Tracker?data=5uPg2cg1ys92-OVw7R9_1UOrqs-jbf2fsK3kvVpGzPQcBsx3jjIom6R0NdIac3MWLGO2DGHlhSGes7jOFqEzD-wQKe1wxWfbPnvlvoC6FUF3V5YGZhHLBwy0Slcsih2HDj2Cf3YE62EGxvyY4GEshA==", "http://adherium.com/investors/", "http://www.openbriefing.com/", "https://www.globenewswire.com/Tracker?data=GhM0slE1wYEp24eNCfPZyVy-RZmJX9Oh_2atX_AtXG4UAejaKeW6e_9w_4HlgsZQLYJh0VuyI3u8uu3p8NtwXI-8JU86D4GL4pvXbxIvkjg=", "https://www.globenewswire.com/Tracker?data=5uPg2cg1ys92-OVw7R9_1UOrqs-jbf2fsK3kvVpGzPQCB2Tuj7g13-liwZy9hOucLGK_b2nodsf8mXg5e6zUaqpfWShkfGYtj1xw3sOS7gc=", "https://www.globenewswire.com/Tracker?data=bDrmSbk-lqrGhTvojlHJOKJplCHfWBAxUD7tjqlXmhonyUl7HiwuXGTs0sHwWz4CrYRSazXFokMcGcRO0AC-6w==", "http://www.openbriefing.com/OB/2812.aspx", "https://www.globenewswire.com/Tracker?data=CJo-We_xZOkvD3l4of72MlTZokcZIZmM_HblYCxKa3d9U6eAGV88IMCAVF3RF3OueVTE0bTZfQ7JQgEJUYgD3NjqPIDcNrGtY08k3Gl4lOs="], "published": "2018-02-07T01:20:00.000+02:00", "crawled": "2018-02-07T04:01:52.109+02:00", "highlightTitle": ""}